| Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes L Zhu, ZG She, X Cheng, JJ Qin, XJ Zhang, J Cai, F Lei, H Wang, J Xie, ... Cell metabolism 31 (6), 1068-1077. e3, 2020 | 1549 | 2020 |
| Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with … P Zhang, L Zhu, J Cai, F Lei, JJ Qin, J Xie, YM Liu, YC Zhao, X Huang, ... Circulation research 126 (12), 1671-1681, 2020 | 1196 | 2020 |
| Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease Z Chen, R Tian, Z She, J Cai, H Li Free Radical Biology and Medicine 152, 116-141, 2020 | 457 | 2020 |
| In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19 XJ Zhang, JJ Qin, XU Cheng, L Shen, YC Zhao, Y Yuan, F Lei, MM Chen, ... Cell metabolism 32 (2), 176-187. e4, 2020 | 448 | 2020 |
| Longitudinal association between markers of liver injury and mortality in COVID‐19 in China F Lei, YM Liu, F Zhou, JJ Qin, P Zhang, L Zhu, XJ Zhang, J Cai, L Lin, ... Hepatology 72 (2), 389-398, 2020 | 393 | 2020 |
| Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta‐analysis F Zhou, J Zhou, W Wang, XJ Zhang, YX Ji, P Zhang, ZG She, L Zhu, J Cai, ... Hepatology 70 (4), 1119-1133, 2019 | 376 | 2019 |
| Epidemiological features of NAFLD from 1999 to 2018 in China J Zhou, F Zhou, W Wang, XJ Zhang, YX Ji, P Zhang, ZG She, L Zhu, J Cai, ... Hepatology 71 (5), 1851-1864, 2020 | 279 | 2020 |
| Antibiotic-loaded nanoparticles targeted to the site of infection enhance antibacterial efficacy S Hussain, J Joo, J Kang, B Kim, GB Braun, ZG She, D Kim, AP Mann, ... Nature biomedical engineering 2 (2), 95-103, 2018 | 238 | 2018 |
| Etchable plasmonic nanoparticle probes to image and quantify cellular internalization GB Braun, T Friman, HB Pang, A Pallaoro, TH De Mendoza, ... Nature materials 13 (9), 904-911, 2014 | 190 | 2014 |
| SIRT1 acts as a modulator of neointima formation following vascular injury in mice L Li, HN Zhang, HZ Chen, P Gao, LH Zhu, HL Li, X Lv, QJ Zhang, R Zhang, ... Circulation research 108 (10), 1180-1189, 2011 | 185 | 2011 |
| Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates PX Wang, YX Ji, XJ Zhang, LP Zhao, ZZ Yan, P Zhang, LJ Shen, X Yang, ... Nature medicine 23 (4), 439-449, 2017 | 180 | 2017 |
| Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice JH Zhou, JJ Cai, ZG She, HL Li World journal of gastroenterology 25 (11), 1307, 2019 | 175 | 2019 |
| An ALOX12–12-HETE–GPR31 signaling axis is a key mediator of hepatic ischemia–reperfusion injury XJ Zhang, XU Cheng, ZZ Yan, J Fang, X Wang, W Wang, ZY Liu, LJ Shen, ... Nature medicine 24 (1), 73-83, 2018 | 161 | 2018 |
| A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries AP Mann, P Scodeller, S Hussain, J Joo, E Kwon, GB Braun, T Mölder, ... Nature communications 7 (1), 11980, 2016 | 160 | 2016 |
| One-step fabrication of polymeric Janus nanoparticles for drug delivery H Xie, ZG She, S Wang, G Sharma, JW Smith Langmuir 28 (9), 4459-4463, 2012 | 149 | 2012 |
| Redefining cardiac biomarkers in predicting mortality of inpatients with COVID-19 JJ Qin, X Cheng, F Zhou, F Lei, G Akolkar, J Cai, XJ Zhang, A Blet, J Xie, ... Hypertension 76 (4), 1104-1112, 2020 | 147 | 2020 |
| The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis P Zhang, PX Wang, LP Zhao, X Zhang, YX Ji, XJ Zhang, C Fang, YX Lu, ... Nature medicine 24 (1), 84-94, 2018 | 138 | 2018 |
| Metformin is associated with higher incidence of acidosis, but not mortality, in individuals with COVID-19 and pre-existing type 2 diabetes X Cheng, YM Liu, H Li, X Zhang, F Lei, JJ Qin, Z Chen, KQ Deng, L Lin, ... Cell metabolism 32 (4), 537-547. e3, 2020 | 134 | 2020 |
| Insights into the epidemiology, pathogenesis, and therapeutics of nonalcoholic fatty liver diseases Y Yu, J Cai, Z She, H Li Advanced Science 6 (4), 1801585, 2019 | 134 | 2019 |
| Interferon regulatory factor 3 constrains IKKβ/NF‐κB signaling to alleviate hepatic steatosis and insulin resistance XA Wang, R Zhang, ZG She, XF Zhang, DS Jiang, T Wang, L Gao, ... Hepatology 59 (3), 870-885, 2014 | 132 | 2014 |
